Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10342875 Stabilized efinaconazole compositions

Patent 10342875 was granted and assigned to Dow Pharmaceutical Sciences on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Dow Pharmaceutical Sciences

0

Current Assignee

Dow Pharmaceutical Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nayan Desai0

Radhakrishnan Pillai0

Varsha Bhatt0

Date of Patent

July 9, 2019

0

Patent Application Number

156075940

Date Filed

May 29, 2017

0

Patent Citations Received

US Patent 12076404 Stabilized efinaconazole compositions as antifungals

0

US Patent 10828293 Anti-infective methods, compositions, and devices

US Patent 10828369 Compositions and methods for treating diseases of the nail

US Patent 10864274 Stabilized efinaconazole formulations

0

US Patent 11654139 Anti-infective methods, compositions, and devices

0

US Patent 11872218 Compositions and methods for treating diseases of the nail

0

Patent Primary Examiner

0

Patent abstract

The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10342875 Stabilized efinaconazole compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool